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Abstract   
The UK’s Royal College of Surgeons (2016) has argued that health professionals 
must replace a ‘paternalistic’ approach to consent with ‘informed choice’. We engage 
with these guidelines through analysis of neurology consultations in two UK-based 
neuroscience centres, where informed choice has been advocated for over a decade. 
Based on 223 recorded consultations and related questionnaire data (collected in 
2012), we used conversation analysis (CA) to identify two practices for offering 
choice: patient view elicitors (PVEs) and option-lists. This paper reports further, 
mixed-methods analyses, combining CA with statistical techniques to compare the 
‘choice’ practices with recommendations. Recommendations were overwhelmingly 
more common. There was little evidence that patient demographics determined 
whether choice was offered. Instead, decisional practices were associated with a range 
of clinical considerations.  There was also evidence that individual neurologists 
tended to have a ‘style’, making it partly a matter of chance which decisional 
practice(s) patients encountered. This variability matters for the perception of choice: 
neurologists and patients were more likely to agree a choice had been offered if a 
PVE or option-list was used. It also matters for the outcome of the decision-making 
process: while recommendations nearly always ended in agreement to undertake the 
proffered course of action, option-lists and PVEs did so only about two-thirds of the 
time. While the direction of causality is unknown, this may indicate that patients are 
better enabled to refuse things they don’t want when neurologists avoid 
recommending.  We argue that our findings imply that neurologists tend to view 
choice as risky – in that the patient might make the ‘wrong’ choice – but that the 
inter-individual variation indicates that greater use of the more participatory practices 
is possible.     
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 2
Keywords: UK; patient choice; doctor-patient interaction; neurology consultations; 
conversation analysis; mixed-methods; decision-making. 
 
1. Introduction 
 
Widely-publicized Royal College of Surgeons’ (RCS, 2016) guidelines on consent 
specify that the aim “is to give the patient the information they need to make a 
decision about what treatment or procedure (if any) they want” (p. 4). The guidelines 
are responsive to the 2015 Supreme Court case of Montgomery vs Lanarkshire Health 
Board in which a woman was awarded damages because her obstetrician had not fully 
explained the risk of vaginal birth in her circumstances (small pelvis, large baby). Her 
baby – starved of oxygen for 12 minutes – was born with cerebral palsy. This case, 
according to the RCS, marks a radical shift in how the consent process is 
conceptualized: 
 
From one in which the surgeon would explain the procedure to the patient and 
obtain their consent to proceed, to one in which the surgeon sets out the 
treatment options and allows the patient to decide (p. 15).  
 
While recognizing that the UK’s General Medical Council has “consistently 
supported patient autonomy”, the RCS argues that “established clinical practice – and 
a large body of case law – [has typically] followed a more paternalistic approach” (p. 
3).  The Montgomery case thus necessitates “a change in attitude from surgeons in 
discussions about consent” (p. 3).  Moreover, the RCS guidance is offered to “other 
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healthcare professionals” (p. 4), implying that similar changes may be needed in other 
specialties. 
 
In this paper, we engage with these guidelines through our investigation of decision-
making in neurology – a specialty where the RCS guidance should already be 
embedded, given that The National Service Framework (NSF) for long-term 
conditions (Department of Health, 2005), in place for over a decade, specifies that 
patients should “receive appropriate information before starting medication to enable 
informed choice” (p. 27). Although the NSF allows for more leeway than the RCS 
guidelines – acknowledging that “not everyone with a long term neurological 
condition will want to participate actively in their own care” (p. 21) – the documents 
share an emphasis on providing information about treatment options. Neurology 
offers an excellent site, therefore, for investigating how (and to what extent) health 
professionals are already acting in accordance with the consent process proposed by 
the RCS.   
 
Our wider project – funded by the UK’s National Institute for Health Research – 
sought to explicate interactional practices used by neurologists to initiate decision-
making with patients. Here, we compare three such practices: recommending, option-
listing and patient view elicitors (PVEs). We argue that, relative to recommending, 
the latter two invite patients to take a more active role in decision-making, and align 
more with the RCS guidelines. It is striking, therefore, that recommendations were 
overwhelmingly more common, even in neurology.  
 
2.  What we already know about real-time decision-making in the clinic 
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Our project builds on previous research on real-time decision-making in the clinic.  
Much of this has focused on the treatment recommendation. Although 
recommendations may be designed in various ways, it is well-established that 
clinicians and patients understand recommendations to be proposals: they are subject 
to the patient’s acceptance, and may be resisted (Costello and Roberts, 2001; Koenig, 
2011; Stivers, 2005). Nevertheless, there is evidence showing how clinicians may 
persuade patients to accept the course of action they think is best (Quirk et al., 2012). 
Hudak et al. (2011) show how surgeons may build their recommendations to try to 
ward off resistance. Stivers (2005) found that parents were less likely to resist a non-
antibiotic treatment recommendation for their child if this was framed as a positive 
recommendation (for a specific alternative), rather than as a recommendation against 
antibiotics. Opel et al. (2013) showed that significantly fewer parents resisted vaccine 
recommendations for their children when the provider used a “presumptive initiation 
format” (i.e. containing a linguistic presupposition of vaccination) as opposed to a 
“participatory” one (i.e. providing parents with more decisional latitude). This 
distinction maps closely onto the focus of our paper.  
 
Collins et al. (2005) drew a related distinction, demonstrating a continuum of 
approaches to decision-making, ranging from ‘unilateral’ (or clinician-determined) to 
‘bilateral’ (or shared).  Illustrating the ‘bilateral’ approach, they showed how 
clinicians sometimes replace the treatment recommendation with efforts to include 
patients actively by, for example, “signposting options in advance of naming them; 
eliciting displays of understanding and statements of preference from the patient” (p. 
2625).   
 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 5
Extending this research, our primary study used conversation analysis (CA) to 
identify two key practices whereby clinicians might invite patients to contribute, 
actively, to decision-making about treatment, investigation or referral options. We call 
these ‘option-lists’ and ‘patient view elicitors’ (PVEs) (Reuber et al., 2015).  In brief, 
option-listing – illustrated below – consists of an explicit listing of alternatives (lines 
2-3, 5-6) from which the patient may choose. This includes an initial announcement 
that there is a decision to be made (line 1).   
 
Example of option-listing (G018; Multiple Sclerosis) 
01  Neu:   And there’s two ways of dealing with this. If you don’t feel that  
02             things are absolutely back to normal… then I can give you some  
03             steroid treatment for a short while. 
            04  Pat:     Mm hm. … 
           05  Neu:    Alternatively I could arrange for you to be seen by one of our  
           06             MS specialists. 
           07  Pat:     Uh huh.  
           08  Neu:   … see if they think that the inflammation…would benefit from some  
           09             other forms of treatment  
 
The identifiers in this paper show where the recording was made (Glasgow or 
Sheffield) and the recording number (numbered consecutively at each site from 001).  
For ease of reading we have not used Jeffersonian transcription notation here, given 
our primary focus on the quantitative analysis.  
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The term ‘patient view elicitor’ incorporates a range of turn designs, which invite the 
patient to express: 
• A preference; e.g. Do you want to try a new drug? (G075) 
• How they “feel” about an option; e.g. What are your own feelings? (G092) 
• Their “thoughts” on a proposed course of action; e.g. What do you think about 
drugs like interferon? (S084) 
• And other variants on this theme; e.g. Is that bad enough that you’d want to 
change drugs? (S060). 
 
All three practices may be designed in varying ways with implications for what sort 
of response is relevant next. The crucial contrast, for our purposes here, is the way in 
which option-lists and PVEs orient to the decision as lying in the patient’s domain.  
Both seek the patient’s active voicing of their position with respect to the option(s), 
while recommendations designedly make explicit which option the neurologist thinks 
is best, only seeking the patient’s acceptance thereof (see Toerien et al., 2013).   
 
The following examples, together with the option-listing example, above, illustrate 
this contrast by showing the same decision type (whether to take steroids) handled 
using each practice. We have seen steroids listed as one option among two 
alternatives. In the following turn, the neurologist also constructs steroid use as 
optional, this time using a PVE, which foregrounds the patient’s wishes: 
 
D’you want to try some steroids? (S080) 
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In our final example, the neurologist, having provided some diagnostic information 
about the patient’s symptoms (not shown), builds on this to justify steroids as his 
recommended course of action, thereby foregrounding his opinion. 
 
And that’s why I want to get the trial of steroids… It kind of depends on how 
things go, but I think five days of steroid tablets, you know, a short sharp 
course…  should give us enough information to see whether or not we need to 
do anything else with it (G042). 
 
 
We understand these three practices as alternative approaches to the same activity: 
initiating – and, for later decision-points, pursuing – a decision about some possible 
treatment, investigation or referral, introduced by the neurologist.   
   
As we have argued previously, although option-lists and PVEs seldom set up an 
entirely open (or neutral) decision, they can be said to offer the patient more of a say 
in the decision-making than recommendations (Reuber et al., 2015). This is for two, 
interrelated reasons. First, recommendations seek acceptance of a conclusion already 
reached by the clinician. Second, although recommendations can be formulated to 
carry different levels of deontic force (Stevanovic and Peräkylä, 2012) – ranging from 
a pronouncement that a particular treatment is necessary, through to a highly 
mitigated suggestion that a treatment might be helpful – recommendations 
unavoidably position the patient as having to respond to an ‘expert opinion’.  To resist 
a recommendation is to go against that expertise.     
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As a practice for initiating decision-making, then, recommendations fall on the ‘old’ 
side of the RCS’s distinction: the approach to consent “in which the surgeon would 
explain the procedure to the patient and obtain their consent to proceed” (p. 15).  
Option-listing, by contrast, maps closely onto the advocated ‘new’ approach, “in 
which the surgeon sets out the treatment options and allows the patient to decide” 
(ibid.).  PVEs lie closer to the ‘new’ approach, in that they also seek the patient’s 
active involvement in the decision-making.  In our primary study, we focused on how 
these two practices could be used to facilitate patient choice (Reuber et al., 2015).  In 
the present study we coded our dataset for quantitative analysis to explore the 
distribution of these practices, and how they compare with recommendations. Our 
aim, following the example of Opel (2013), Robinson (2007) and Stivers (2015), was 
to reduce the interactional data - for quantitative analysis - without sacrificing a CA 
sensibility. We therefore worked iteratively from the recordings and retained as much 
interactional information as possible by maintaining sequential ordering and capturing 
both neurologists’ initiating turns and patients’ immediate responses (see Reuber et 
al., 2015 and forthcoming for analysis of the latter) across often extended decision-
making trajectories.  
 
3. Methods 
 
3.1 Recruitment and data collection 
Our primary dataset of 223 audio/video recordings of neurology outpatient 
appointments was collected in 2012 in two major clinical neuroscience centres (in 
Glasgow and Sheffield). Neurologists and patients also completed questionnaires 
before and after their recorded consultation.  Fourteen neurologists (seven at each 
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site), 223 patients (114 in Glasgow, 109 in Sheffield), and 114 accompanying others 
(63 and 51, respectively) took part. Clinicians opted in to the study, providing written 
consent.  Patients received advance, written information about the study.  Dedicated 
study research assistants conducted informed consent discussions with patients (and 
accompanying others), taking written consent as appropriate.  All participants were 16 
years or older and able to consent in English.  All could choose whether their 
consultations were audio- or video-recorded. The research assistants operated the 
recording equipment and provided help with the questionnaires, but were not present 
during the consultations.  Ethics approval was granted by the National Research 
Ethics Service Committee for Yorkshire & the Humber (South Yorkshire) on 11 
October 2011 and by the Proportionate Review Sub-committee of the NRES 
Committee North West (Greater Manchester South) on 20 July 2015. 
 
3.2 Coding the recordings 
This study was designed to compare neurologists’ recommendations, option-lists and 
PVEs. Based on our previous qualitative findings (Reuber et al., 2015), we produced a 
coding scheme through an iterative bottom-up process to capture what was going on 
in the interactions. Hence, we developed a set of inclusion criteria based on the three 
focal practices and three recurrent types of decision: treatments, investigations and 
referrals. We developed a codebook and extraction form (available from the 
corresponding author).  Working from the audio recordings (because we had those for 
all cases) in conjunction with their verbatim transcripts, the following were identified:   
• All decisions about treatments, investigations or referrals initiated by the 
neurologist using one of our three core practices. 
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• Many decisions entailed extended sequences, with multiple decision-points 
(e.g. a recommendation followed by an option-list, then a PVE).  We coded 
every option-list, PVE or recommendation that occurred across each decision 
type meeting our inclusion criteria.  Our coding retained the sequential 
ordering, allowing us to compare first decision-points with later ones.   
• For each decision, we noted whether one or more of the possible courses of 
action had been agreed upon by the end of the consultation.  Coders could 
select ‘yes’, ‘no’ or ‘decision deferred’.  The goal was to note whether a 
proffered course of action was going ahead in principle (we do not have the 
data to assess whether these actually occurred).  For option-listing, if any 
listed option was agreed upon, coders selected ‘yes’.  For PVEs, if the patient 
opted for a course of action proffered through the PVE – be that specific (e.g. 
a named drug) or general (e.g. ‘treatment’ for their condition) – then coders 
selected ‘yes’. To handle recommendations against doing something, coders 
recorded ‘yes’ if the decision was in favour of a ‘negative’ course of action 
(e.g. agreeing not to change a medication).  
• For each decision-point, we identified how the patient and/or accompanying 
other responded in next position. Due to space constraints, we do not report 
analyses of this here (see Reuber et al., forthcoming).  
 
The resulting spreadsheet contained our interactionally-grounded quantitative codes 
and the relevant data extracts, facilitating our ability to move between a qualitative 
and quantitative approach. The figure provided as a ‘Supplementary File’ illustrates 
our coding process, showing how a single consultation might have more than one 
decision and how decisions may have one or more decision-point. Given that our aim 
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was to compare recommendations, option-lists and PVEs, we did not attempt to code 
all possible ways in which a decision might be negotiated. To ensure we were 
comparing neurologist-initiated decisions, we excluded patient-initiated ones.  
 
 
3.3 Inter-coder reliability 
To test the reliability of our coding, three coders independently coded 20 
consultations, sharing 10 with each of the others (30 consultations, or 13.5% of the 
dataset). Inter-coder agreement of the 39 first decision-points across the 30 
consultations was checked. Agreement on when the first decision-point occurred was 
74% - a large majority of cases.  Percentage agreement and Kappa scores were 
calculated for each variable.  Of the variables pertinent for this paper, agreement was 
79.4% for the classification of decision-points (Kappa = 0.70) and 97.4% for the 
agreed outcome variable (Kappa = 0.92).  This shows that there was some 
disagreement, indicative of the nuanced ways that decisions are initiated. However, 
these kappa values indicate ‘substantial’ and ‘outstanding’ agreement respectively 
(Landis and Koch, 1977), sufficient for quantitative analyses.  
 
Coders subsequently negotiated agreements on all aspects of coding for the 30 cases 
before the remainder of the coding was conducted.  The resulting quantitative data 
were then recoded into forms suitable for analysis.   
 
3.4 Coding the questionnaires 
Participant demographics and variables recording aspects of the patient’s condition 
were derived from the questionnaire responses.  These included the extent to which 
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neurologists considered patients’ symptoms to be medically explained 
(‘completely/largely explained’, ‘partly explained/partly unexplained’ and 
‘completely/largely unexplained’) and how certain they were of the diagnosis (rated 
from very uncertain (1) to very certain (10)).  We employ variables that record the 
length of the consultation, which neurologist provided the consultation, and whether it 
took place within a general neurology or specialist clinic (e.g. Multiple Sclerosis or 
Epilepsy clinics).  The six neurologists who recorded fewer than eight consultations 
each were combined into ‘remainder’ groups from Glasgow (three consultants) and 
Sheffield (three consultants).  In post-consultation questionnaires, patients were 
asked: ‘Did the doctor give you a choice about any tests or treatment you might have 
or the next step in the management of your condition’, and neurologists were asked: 
‘Did you give the patient a choice about treatment or further management?’ A 
variable that described patient and neurologist agreement on whether choice had been 
offered was derived.  Descriptive details for these variables can be seen in Tables 3, 4, 
and 5. 
 
3.5 Analytic approach 
Quantitative analysis consisted of a three-stage descriptive, exploratory process.  
First, we mapped the distribution of the three practices across consultations, 
decisions, and decision-points (Figure 1 and Table 1).  Second, the bivariate links 
between interactional practices and demographic and clinical variables were 
investigated (Tables 2, 3, 4, and 5, and 7) and two binary logistic regression models 
were estimated (Table 6), using Generalized Estimating Equations Modelling to 
adjust for the clustered nature of the data.  The dependent variable in both models is 
the binary variable classifying each consultation as either containing at least one PVE 
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and/or option-list or only containing recommendations.  For independent variables, 
we included all demographic and clinical variables showing an association (at the 0.2 
level) with interactional practices, in order to identify independent predictors of these 
practices, excluding the individual neurologist variable, as this led to overfitting.  
Specification 1 includes all relevant variables, whereas Specification 2 excludes the 
variables with greater than 5% missing values from the analysis, in order to preserve a 
higher N.  Third, we investigated the bivariate links between practice and outcomes to 
explore the extent to which different practices may lead to differing levels of take-up 
of the options proffered by the neurologist (Table 8).  Bivariate associations were 
investigated using contingency tables, Chi square tests, ANOVA, and correlation, as 
appropriate. In all analyses, we report p values at 0.1, 0.05, 0.01 and .001 levels and 
consider p-values below 0.05 to indicate statistical significance. 
 
Some participants did not fully complete the questionnaires.  Additionally, not all 
consultations contained a decision, as defined by our coding scheme.  To deal with 
missing data, we took the 144 recordings with at least one decision meeting our 
inclusion criteria as our working sample, and used listwise deletion for the remainder 
of our analyses.  The frequency of missing values for each of the different variables is 
shown in Tables 3 and 4.  
 
4. Findings 
 
4.1 Decisions and decision-points 
Most consultations (144/223 or 65%) included at least one decision initiated by the 
neurologist through an option-list, PVE or recommendation.  Figure 1 shows the 
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frequency of decisions across the 144 consultations with at least one decision, and the 
frequency of decision-points per decision.  Decisions per consultation ranged from 1 
to 4 (median 1), with single-decision consultations making up 51.4% of consultations.  
Decision-points per decision ranged from 1 to 11 (median 2).  A large majority 
(96.4%) included 5 or fewer decision-points.  At a gross level, the number of 
decision-points can indicate patient resistance.  The longest chain, for example, 
involved a patient’s resistance to, and neurologist’s pursuit of, a recommendation for 
further investigations. We do not report analyses of decision-points here (but see 
Reuber et al., forthcoming). However, it is worth noting that option-lists have a higher 
average number of follow-up decision-points (2.5 per decision) than 
recommendations (1.6) and PVEs (1.2). 
 
Figure 1 here 
 
4.2 Distribution of practices across consultations, decisions, and decision-points 
Table 1 shows the distribution of option-listing, PVEs and recommendations across 
the sample.  By far the most common practice was the recommendation, followed by 
the PVE, then the option-list, which was comparatively rare.  This was the case 
whether considering the percentage of consultations, decisions, decision-points, or 
first decision-points.   
 
Table 1 here 
 
4.3 Distribution of practices across decision types (treatments, investigations, 
referrals) 
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Treatment decisions were most common (over 60%), 29% were investigation 
decisions, and less than 10% referral decisions.  Only a very small proportion of 
decisions (n=2, 0.8%) included more than one decision type (for example option-lists 
that included an investigation and treatment option).  Table 2 shows the distribution 
of the practices across decision types, at decision level.  Cases with multiple types of 
decision are excluded because of the low numbers.  Table 2 reveals that 
recommendations were the most common practice across all decision types and 
option-lists were the least common.  However, the proportions of the practices used 
for different decision types differed significantly. Investigations were characterised by 
very high numbers of recommendations, whereas treatment and referral decisions 
were relatively more likely to include option-lists and PVEs. 
 
Table 2 here 
 
4.4 Perception of choice 
Table 3 shows relationships between interactional practice and perceived choice.  
Both neurologists and patients were more likely to report that a choice had been 
offered in consultations containing at least one option-list or PVE.  There is a 
particularly strong relationship between perception of choice and use of option-lists or 
PVEs when the participants agreed choice was offered (see Reuber et al., 
forthcoming). These findings indicate that the understanding of option-lists and PVEs 
as mechanisms for offering choice is not just an analytic judgement; participants 
themselves typically perceived consultations containing these practices as offering 
choice, and those containing only recommendations as not offering choice.  
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Table 3 here 
 
4.5 Geographic, patient demographic and clinical factors 
Tables 4 and 5 show the links between decisional practices and geographic, patient 
demographic, and clinical factors (there were too few neurologists to conduct tests 
based on their demographic characteristics).  More PVEs and option-lists were used in 
the Sheffield consultations and more recommendations in the Glasgow consultations.  
We do not report other geographical differences in detail because we have done so 
previously for the full sample (n=223) (Wiseman et al., 2016) and the characteristics 
of the working sample (n=144) are very similar.  To summarize the differences, 
Glasgow consultations were more likely to be held in general clinics and tended to be 
shorter.  Symptoms were more likely to be “medically explained” in Sheffield 
consultations. 
 
Table 4 here 
 
Tables 4 and 5 demonstrate that the practice employed was largely unrelated to 
patients’ demographic characteristics.  Different practices were no more or less likely 
to be employed based upon patients’ gender, ethnicity, educational level (which can 
be seen as a proxy for social class (Galobardes et al., 2007)) or work status.  
However, one of the two multivariate analyses (Specification 2, Table 6) indicates 
that younger patients were more likely to be given option-lists or PVEs, after other 
variables were controlled for.   
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By contrast, clinical factors and factors relating to the type of consultation were more 
commonly related to the practice employed.  Bivariate analyses show neurologists 
were more likely to use option-lists or PVEs when they were more certain about a 
diagnosis and when the symptoms were medically explained.  They were also more 
likely to use these two practices in follow-up (than first) appointments.  There was 
some evidence that PVEs and option-lists were more likely to be used in specialist 
(than general) clinics, although this difference was not significant at the 0.05 level.  
There was no relationship between consultation length and the practice employed.  
Most of these associations do not remain significant after controlling for other 
variables (Table 6), but PVEs or option-lists were still more likely to be employed in 
consultations where neurologists were more certain of their diagnoses.  
 
Tables 5 and 6 here 
 
4.6 Individual differences between neurologists 
Table 7 shows the differences between neurologists regarding their use of the three 
practices. We have insufficient sample size to employ inferential statistical (chi 
square) tests to investigate the differences between neurologists for one or more 
option-list vs. no option-list.  Nevertheless, it is clear from the descriptive statistics 
and comparisons between 1 or more PVE and no PVE that there were large 
differences between neurologists in how often they employed PVEs or 
recommendations.  Two contrasting cases highlight how individuals may exhibit a 
‘style’ of decision-making: Sheffield 4 recorded no consultations containing only 
recommendations, and employed PVEs in all 19 consultations, whereas Glasgow 1 
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used recommendations in all 14 consultations, and used a lower combined proportion 
of PVEs and option-lists than any other neurologist.   
 
Table 7 here 
 
One potential explanation is that certain subspecialties may be more suited to certain 
forms of decision-making.  However, a specialism–based explanation of individual 
differences does not appear to offer a good account for the patterning seen here, 
because, as Table 4 shows, there is no significant link between specialism and 
decisional practices.  The above examples again illustrate this point: both Sheffield 4 
and Glasgow 1 are from the same subspecialty. 
 
4.7 Outcome: is the proffered course of action going ahead in principle? 
Table 8 shows the links between practices and an important outcome measure: 
whether agreement was reached that a course of action made available by the 
neurologist was going to be acted upon by the patient.  Crucially, when only 
recommendations were used, nearly all (98.6%) decisions concluded with the 
recommended course of action agreed in principle.  By contrast, agreement was 
reached in only 68.6% of cases with a PVE or option-list.  Thus, rejection of the 
proposed course of action – or deferral of a decision – was far more likely when PVEs 
or option-lists were employed (although the direction of causality is unknown).  
 
Table 8 here 
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5. Discussion 
 
The recent RCS (2016) guidance on consent proposes, in effect, that health 
professionals should (largely) abandon recommending in favour of option-listing 
together with a PVE to invite the patient’s selection from the list.  Our findings show 
that, despite long-standing guidance that patients should be enabled to make an 
“informed choice” (Department of Health, 2005, p. 27), recommending remains the 
primary means through which neurologists initiate decision-making.  Moreover, 
option-listing was rare: there were around 13 recommendations for every option-list.  
On our measures, patients were offered choice in only about half the recorded 
consultations.  Current practice in neurology thus appears to map more closely onto 
the ‘old’ approach articulated by the RCS – where clinicians explain the procedure 
and seek consent – than the practice advocated: where clinicians set out the options 
and let patients decide.  This coheres with a range of findings regarding the 
inconsistency of participatory decision-making more broadly (e.g. Couët et al., 2015; 
Elwyn et al., 2013; Jones et al., 2014), and in neurology specifically (e.g. McCorry et 
al., 2009; Palace, 2013; Pietrolongo et al., 2013). 
        
We explored whether our findings might be explained by clinician ‘bias’ regarding 
patients’ sociodemographic status (cf. Aelbrecht et al., 2015; Waitzkin, 1989; 
Willems et al., 2005).  However, apart from younger patients being more likely to be 
offered ‘choice’ – which might reflect an assumption that young adults prefer choice 
and elderly people prefer to be told what is best (e.g. Levinson et al., 2005) – we 
found no significant relationships between the practices and patient demographics.  
Rather, three factors seem to be most relevant:  
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1) Clinic location – option-listing and PVEs were more commonly used in 
Sheffield than Glasgow; 
2) The individual clinician; 
3) Clinical considerations. Option-lists and PVEs were more commonly used for 
treatment than investigation decisions and if there was greater certainty about 
the diagnosis. Bivariate analyses also indicated PVEs and option-lists were 
more likely to be used if symptoms were medically explained, and in follow-
up appointments.  
 
It is hard to pick apart the relative importance of these factors because we were unable 
to properly control for the influence of individual clinicians in our multivariate 
analyses.  However, the most convincing reading of our descriptive analyses is that 
the first factor – geographical differences – may not represent ‘cultural’ differences 
between Glasgow and Sheffield.  Rather, the importance of geography is likely 
explained by the idiosyncrasies of the individual neurologists and the clinical 
situations common in those clinics, because both of these factors contribute to 
skewing the distribution of practices in favour of more ‘choice’ in Sheffield.   
 
The evidence for individual decision-making ‘styles’ among neurologists in our 
sample is strong, even within subspecialties; whether patients are offered a choice is 
partly based on which neurologist they see. This is key in the UK context of 
secondary care, which operates a referral system via the patient’s general practitioner.  
Although patients do have (limited) rights to choose their consultant, the allocation is 
typically made for them.  Our study shows that this variability matters, firstly, for the 
perception of choice, since neurologists and patients were far more likely to report 
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that a choice was offered in consultations where option-lists or PVEs were employed.  
Secondly, while our data do not allow for definitive conclusions regarding the 
direction of causality, our findings also suggest that option-lists and PVEs may enable 
choice in practice.  Given that recommendations nearly always ended in agreement 
that the proffered course of action would go ahead, but option-lists and PVEs ended in 
agreement only about two-thirds of the time, it may be that the latter practices 
facilitate more independent decision-making by patients.  This may explain the more 
even split between agreement and refusal in response to option-lists and PVEs relative 
to recommendations, where patients might be more likely to ‘go along with’ the 
expert opinion.  This interpretation is supported by Opel et al.’s (2013) finding that 
‘participatory’ approaches were less likely than ‘presumptive’ approaches to lead to 
parents agreeing to vaccinate their children (the option clinicians thought best).   
 
However, it is also possible that neurologists are more likely to use option-lists and 
PVEs when they already have reason to think patients might resist the proffered 
course of action (e.g. they know the patient’s treatment preferences).  Moreover, since 
our study was not designed to assess the relative clinical significance of decisions, we 
cannot be sure whether the neurologists – insofar as they departed from their 
individual styles – were selecting practices based on some form of risk/benefit 
analysis.  Certainly, the complex combination of clinical factors associated with 
whether the neurologists opted to recommend (vs. offering choice) suggest that they 
perceive choice as risky – the patient might choose what they consider to be the 
‘wrong’ option. Clinicians may therefore choose a more directive approach if they 
believe the clinical stakes are too high.  
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Our qualitative analysis provides support for this.  For example, we have observed a 
two-step process for anti-epileptic drug decisions, where the neurologist recommends 
that a patient with poorly controlled epilepsy try a different drug, but switches to 
option-listing regarding which drug to try.  This is an example of choice being offered 
where the diagnosis is certain and medically explained, typically in a specialist clinic, 
at a follow-up appointment, with a patient who may well have prior experience of 
choosing between anti-epileptics.  Nevertheless, choice is offered for that part of the 
decision for which the neurologist has: a) less evidence regarding which option is 
best, and b) good reason to seek the patient’s views given that drugs have different 
risks.  With respect to the decision to change drugs, the neurologist prioritises the 
‘duty of care’ over offering choice.  This aligns with Quirk et al.’s (2012) finding that 
there was a somewhat higher level of risk associated with more pressured and directed 
decisions (vs. more open ones) in UK psychiatric consultations. 
  
The strong tendency for neurologists to recommend when making decisions about 
investigations (vs. treatments and referrals) may also be understood as supporting this 
analysis.  Given that patients have as much legal right to refuse investigations as they 
have to refuse treatment (Department of Health, 2015) one might expect no such 
relationship between practice and decision type.  However, it seems that neurologists 
regularly prioritise their view of what is best over the ‘informed choice’ policy when 
they consider there to be sufficient diagnostic uncertainty to warrant (further) testing.  
In such cases, not only is there often the risk of missing a serious diagnosis, but 
testing is typically positioned as a precursor to identifying a solution to the patient’s 
complaint.  Foregrounding the patient’s right to choose whether to test might thus be 
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viewed as risky – particularly if treatment differs depending on the diagnosis (e.g. for 
epileptic vs. non-epileptic seizures).  
 
Thus, we appear to be seeing a complex interplay between the exercise of epistemic 
(Heritage, 2012) and deontic authority (Stevanovic & Peräkylä, 2012), with 
neurologists being more likely to tell patients what to do when less certain of the 
diagnosis, and more likely to give patients a choice when they are better placed to 
weigh up the risk/benefit ratio of doing so.  This may be understood as another 
instantiation of the ‘risk-choice paradox’, compellingly demonstrated in maternity 
care (Symon, 2006), where there is, simultaneously, a strong emphasis on avoiding 
risk and enabling choice for the woman in labour.   
  
Our ongoing qualitative analysis also suggests that neurologists and patients orient to 
decisions about investigations as lying predominantly in the neurologist’s domain, 
while treatment decisions are understood as more open to joint negotiation (e.g. 
Costello and Roberts, 2001).  This may be partly because investigations are 
understood as a component of the diagnostic activity – which is treated as largely a 
matter for the ‘experts’ (Heath, 1992) – and partly because the responsibility for 
carrying out tests lies with the healthcare service.  Moreover, many tests are one-offs, 
carrying little risk of serious side effects for the patient, thus making their conduct 
relatively straightforward from a medical point of view.  By contrast, many treatments 
require the patient to take responsibility for self-administering injections or tablets 
(often at a particular time) and may necessitate strategies for dealing with ongoing 
side effects.  Thus, in addition to the evidence that neurologists appear to be using 
different practices based on their assessment of the risk associated with a ‘wrong’ 
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choice, it appears that they are also attuned to the relative rights and responsibilities of 
each party regarding the decision being made.  
  
Nevertheless, our findings clearly demonstrate that the same activity – decision-
making – and even the same decision regarding the same condition in the same 
subspecialty, can be handled differently.  This shows the more participatory practices 
can be used even in (some) situations where some clinicians routinely recommend.  
Our findings have three key implications: i) Given that recommending is 
overwhelmingly common, even in neurology, this is likely to be so across a range of 
specialties.  The RCS guidance is right, then, to suggest that a more ‘paternalistic’ 
approach – where the doctor advises the patient to do what s/he considers best – 
remains part of established practice; ii) We believe that this is partly explained by 
doctors’ concerns that choice may be risky for patients (they may make the ‘wrong’ 
choice); iii) Nevertheless, some neurologists have developed a more ‘choice-oriented’ 
style, and here we note that the neurologist who offers most choice works in a 
specialist clinic, with patients whose symptoms are medically explained, and hence 
has exactly the basis for offering choice suggested by our findings. Further, all the 
neurologists do – at least on occasion – offer choice.  Thus, the potential to expand 
the implementation of patient choice (should this be appropriate) is already within 
neurologists’ ‘repertoire’.     
 
To our knowledge, our study is the first to map out, across a relatively large dataset of 
recorded consultations, the relationship between recommendations and practices that 
are demonstrably understood as offering choice, and a complex array of demographic 
and self-report variables of clinical relevance.  This has allowed for a nuanced 
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understanding of how neurologists initiate decision-making in real-time.  The study 
has its limitations, including those imposed by sample size (e.g. we were unable to 
conduct inferential analyses of neurologists’ demographics), and the nature of our 
dataset. For example, we were able only to judge ‘outcomes’ based on conversational 
and self-report data.  We have not tracked what happened following the consultations 
and do not have measures of physical or mental health that might have been a 
consequence of decisions taken.  Further research is warranted.    
 
We are also aware that the concept of ‘choice’ is contested and relatively poorly 
understood in interactional practice (Pilnick, 2008).  We have focused on option-
listing and PVEs because: a) our qualitative work showed how they were used to 
create explicit moments of choice; b) participants reported perceiving choice in those 
consultations where these practices were used; and c) option-lists and PVEs map onto 
the ‘informed choice’ ideal as articulated in NHS policy and guidance documents.  
Nevertheless, other practices will undoubtedly play a role in the perception of choice 
and its enactment.  Moreover, as our qualitative work has shown, these practices do 
not guarantee that patient choice is enabled, and can be used as strategies to pursue 
the neurologist’s agenda (Reuber et al., 2015).  Such complexities, while making 
further qualitative work necessary, underscore the significance of our quantitative 
findings: despite the potential for all three practices to be used in atypical ways, the 
evidence strongly supports our claim that option-lists and PVEs, but not 
recommendations, are understood as making choice available.    
 
In summary, neurologists do not appear to be adhering, systematically, to the 
guidelines on patient choice.  However, ‘one-size-fits-all’ guidelines that uphold a 
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particular practice are, we would argue, unhelpful, both because they fail to take into 
account the complex balancing act that clinicians are demonstrably performing when 
selecting between alternative practices, and because these are not always enacted as 
policy-makers might intend.  To enact a patient-centred approach in a meaningful way 
requires health professionals to engage, not in rote-learning of a formula for consent, 
but in reflective practice.  This should include understanding the implicit interactional 
decisions (e.g. using an option-list, PVE and/or recommendation) they must make 
every time they initiate a substantive decision-making trajectory with a patient.   
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Figure caption 
Figure 1.  Frequency of decisions per consultation (only including consultations with 
at least 1 decision) (left, n=246) and frequency of decision-points per decision (right, 
n=623).  
  
Tables 
Table 1.  Distribution of the practices across consultations, decisions, and decision-
points (row %) 
 
  
    Recommendations PVEs Option‐lists 
PVEs or option‐
lists 
No PVE or option‐
list (only 
recommendations) Total 
Consultations n 131 77 24 80 64 144 
  % 91% 53.5% 16.7% 55.6% 44.4% n/a 
Decisions n 207 105 27 105 141 246 
  % 84.1% 42.7% 11.0% 42.7% 57.3% n/a 
All decision‐
points n 439 149 34 183 439 623 
  % 70.6% 23.9% 5.5% 29.4% 70.6% 100% 
First decision‐
points n 173 58 15 73 173 246 
  % 70.3% 23.6% 6.1% 29.6% 70.3% 100% 
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Table 2.  Forms of practice used for different types of decisions (column %) 
    Investigation Treatment Referral Total 
Decisions           
At least one recommendation Count 64 124 17 205 
  % 90.1%* 82.7%* 73.9%* 84.0% 
At least one option‐list Count 1 20 4 25 
  % 1.4%* 13.3%* 17.4%* 10.2% 
At least one PVE Count  17 67 14 98 
  % 23.9** 44.7** 60.9** 40.2 
At least one PVE or Option‐list Count 17 71 15 103 
  % 23.9%*** 47.3%*** 65.2%*** 42.2% 
*** p ≤ 0.001 
** p ≤ 0.01 
* p ≤ 0.05 
~ p ≤ 0.1 
NB. Statistical tests show comparisons between 1 or more recommendation and no recommendation; 1 or more PVE and 
no PVE; 1 or more option-list and no option-list; and at least 1 PVE or option-list and no PVE or option-list. 
 
Table 3. Decisional practice and perception of choice (column %) 
  Option list or PVE No Option list or PVE Total 
        
N 80 64  144 
        
Patient choice n=75 n=59  n=134 
Choice 81.3%** 59.3%** 71.6% 
No choice 18.7%** 40.7%** 28.4% 
Clinician choice n=78 n=63  n=141 
Choice 83.3%*** 52.4%*** 69.5% 
No choice 16.7%*** 47.6%*** 30.5% 
Patient-doctor 
agreement on choice n=73 n=59  n=132 
Agree choice 71.2%*** 33.9%*** 54.5% 
Agree no choice 6.8%*** 22.0%*** 13.6% 
Patient no doctor yes 12.3%*** 18.6%*** 15.2% 
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***
 p ≤ 0.001 
** p ≤ 0.01 
* p ≤ 0.05 
~ p ≤ 0.1 
 
NB. Statistical tests show comparisons between at least 1 PVE or option-list and no PVE or option-list. 
 
Table 4.  Distribution of patients from different demographic groups and with 
different clinical characteristics, and distribution of different types of consultations, 
across consultations containing different decisional practices. Categorical variables. 
(row %) 
 
 
At least 1 PVE or 
option‐list 
No PVEs or option‐lists 
(only recs) 
All  55.6% (n=80) 44.4% (n=64) 
Location     
Sheffield 67.1%** 32.9%** 
Glasgow 43.7%** 56.3%** 
Clinic type     
Seen in general clinic 41.7%~ 58.3%~ 
Seen in specialist clinic 58.3%~ 41.7%~ 
Specialism     
General (n=25) 44.0% 56.0% 
Epilepsy (n=37) 54.1% 45.9% 
Headache / vascular (n=11) 45.5% 54.5% 
MS (n=42) 64.3% 35.7% 
Neuromuscular (n=10) 50.0% 50.0% 
Other sub specialism (n=19) 63.2% 36.8% 
Patient Accompanied?     
Accompanied 54.1% 45.9% 
Alone 57.1% 42.9% 
First appointment? n=67 n=45 
First appointment 45.5%* 54.5%* 
Patient yes doctor no 9.6%*** 25.4%*** 16.7% 
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Follow‐up appointment 65.8%* 34.2%* 
Symptoms      
Completely / largely explained 61.8%* 38.2%* 
Partly explained 44.1%* 55.9%* 
Completely Unexplained 37.5%* 62.5%* 
Patient’s Gender     
Female 53.9% 46.1% 
Male 58.2% 41.8% 
Ethnicity     
White British 56.1% 43.9% 
Other 50.0% 50.0% 
Post-school quals? (n=119) n=67 n=52 
Post‐school quals 60.0% 40.0% 
No post‐school quals 53.6% 46.4% 
Work status (n=143) n=79 n=64 
In work / education / other 57.5% 42.5% 
Not working due to ill health  48.6% 51.4% 
Employment      
Employed 61.5% 38.5% 
Not employed 52.2% 47.8% 
*** p ≤ 0.001 
** p ≤ 0.01 
* p ≤ 0.05 
~ p ≤ 0.1 
NB. Statistical tests show comparisons between at least 1 PVE or option-list and no PVE or option-list. 
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Table 5. Distribution of patients from different demographic groups and with different 
clinical characteristics, and distribution of different types of consultations, across 
consultations containing different decisional practices. Continuous variables.  
    
At least 1 PVE / 
or option‐list  
No PVE or 
option‐list 
(only recs) All 
Patient age Mean 44.5 48.1 46.1 
  S.D. 14.1 15.6 14.8 
          
Certainty Mean 8.74* 8.0* 8.41 
  S.D. 1.7 1.9 1.8 
Duration Mean 22.3 20.1 21.3 
  S.D. 10.9 11.6 11.2 
*** p ≤ 0.001 
** p ≤ 0.01 
* p ≤ 0.05 
~ p ≤ 0.1 
 
NB. Statistical tests show comparisons between at least 1 PVE or option-list and no PVE or option-list. 
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Table 6.  Multivariate predictors of decisional practice (Odds ratios of consultation 
containing at least one PVE or option-list) 
 
    Specification 1 (n= 112) Specification 2 (n= 144) 
    OR 95% CI OR 95% CI 
Site Glasgow 0.45 0.17 ‐ 1.31 0.37* .15 ‐ .91 
Clinic type General 0.42 0.12 ‐ 1.40 0.68 0.23 ‐ 2.02 
Symptoms Completely unexplained 1.31 0.29‐ 5.83 2.3 .70 ‐ 7.45 
  Partly explained 0.94 .33 ‐ 2.67 1.44 .55 ‐ 3.76 
First appointment? First 0.46 .16 ‐ 1.31 ‐‐ ‐‐ 
Certainty   1.59* 1.20‐ 2.09 1.30~ .97 ‐ 1.7 
Age   0.98 .95 ‐ 1.01 
0.91* 
.95 ‐ 0.99 
*** p ≤ 0.001 
** p ≤ 0.01 
* p ≤ 0.05 
~ p ≤ 0.1 
NB. Dependent variable reference category is no PVE and/or option-list (only recommendations).  
 
Table 7.  Individual neurologists’ use of different decisional practices (row %)  
 
 
At least one 
recommendation At least 1 PVE At least 1 Option‐list 
    
All     91.0% 55.6% (n=80) 44.4% (n=64) 
    
Neurologist      
Sheffield 2 (n=10) 90%** 50.0%** 0.0%ᵃ 
Sheffield 3 (n=14) 85.7%** 50.0%** 7.1%ᵃ 
Sheffield 4 (n=19) 73.7%** 100.0%** 36.8%ᵃ 
Sheffield 6 (n= 12) 100.0%** 41.7%** 25.0%ᵃ 
Sheffield rest (n=18) 83.3%** 72.2%** 22.2%ᵃ 
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Glasgow 1 (n=23) 100.0%** 30.4%** 4.3%ᵃ 
Glasgow 2 (n=13) 92.3%** 38.5%** 0.0%ᵃ 
Glasgow 4 (n=12) 100.0%** 41.7%** 41.7%ᵃ 
Glasgow 5 (n=14) 100.0%** 35.7%** 21.4%ᵃ 
Glasgow rest (n=9) 88.9%** 66.7%** 0.0%ᵃ 
ᵃSignificance testing not employed for this comparison 
*** p ≤ 0.001 
** p ≤ 0.01 
* p ≤ 0.05 
~ p ≤ 0.1 
NB. Statistical tests show comparison between at least 1 recommendation and no recommendation; and at least one PVE and no 
PVE. 
 
Table 8. Forms of decisional practice used and whether recommended courses of 
action are agreed to happen in principle (column %) 
   
  
At least 1 PVE or 
option‐list 
No PVE or option‐ 
list (only recs) Total 
N 105 141 246 
Decision deferred 11.4%*** 0.0%*** 4.9% 
No  20.0%*** 1.4%*** 9.3% 
Yes 68.6%*** 98.6%*** 85.8% 
*** p ≤ 0.001 
** p ≤ 0.01 
* p ≤ 0.05 
~ p ≤ 0.1 
NB. Statistical tests show comparisons between at least 1 PVE or option-list and no PVE or option-list. 
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Figure 1.  
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Research highlights  
 
 
• Recommendations were far more common than patient view elicitors or option-lists.   
• Use of the practices was largely not associated with patient demographics. 
• Whether patients were offered choice partly depended on which neurologist they saw. 
• Recommendations were more likely to end in agreement to treat/investigate/refer.   
• Neurologists treat ‘choice’ practices as risky but could expand their use thereof. 
  
 
